Precision Medicine Market Size PowerPoint PPT Presentations

Global Precision Medicine Market Report 2020 - Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global Precision Medicine industry.

Global artificial intelligence (ai) in precision medicine market size is expected to reach $6.86 Bn by 2028 at a rate of 30.4%, segmented as by component, hardware, software, service

Global artificial intelligence (ai) in precision medicine market size is expected at $5.22 Bn by 2027 at a growth rate of 30.1%.

According to P&S Intelligence, the precision medicine market generated $203.5 billion in 2019 and it is expected to reach $738.8 billion by 2030, progressing at a CAGR of 12.1% during the forecast period (2020–2030). This growth can be driven by the rising government support, escalating awareness regarding personalized treatments, rising number of approved personalized medications, increasing use of artificial intelligence (AI) in clinical trials related to precision medications, surging number of regulatory approvals, soaring cases of chronic and genetic diseases, and flourishing medical tourism industry.

The global precision medicine market is expected to grow from $62.75 billion in 2020 to $72.58 billion in 2021 at a compound annual growth rate (CAGR) of 15.7%.

Precision Medicine Market size was over USD 39 billion in 2015, and is anticipated to grow at 10.5% CAGR from 2016 to 2023.

This report focuses on the global Precision Medicine Diagnostics status, future forecast, growth opportunity, key market and key players.

This report focuses on the global Precision Medicine Software status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Precision Medicine Software development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The global oncology precision medicine market was estimated to be worth $49.4 billion in 2021, and it is expected to reach $ 124.84 billion by 2030, expanding at a CAGR of 10.85% from 2021 to 2030 For more info - https://straitsresearch.com/report/oncology-precision-medicine-market

According to the latest research report by IMARC Group, The United States precision medicine market size is projected to exhibit a growth rate (CAGR) of 7.10% during 2024-2032. More Info:- https://www.imarcgroup.com/united-states-precision-medicine-market

Precision Medicine Market size is $113.76Bn in 2019, growing at a CAGR of 13.2% during the forecast period 2020-2025. Precision medicine is also called personalized medicine or individualized medicine is an approach that protects health and treat diseases taking into account an individual variability in genes, environment and lifestyle for every individual.

The global Radiopharmaceuticals/Nuclear Medicine Market was valued at US$ 5605 Million in 2022 and is anticipated to grow at US$ 9327 Million by 2029 recording a CAGR of 9.3% during the forecast period 2023-2029. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=17441

Precision Medicine Market size is $113.76Bn in 2019, growing at a CAGR of 13.2% during the forecast period 2020-2025. Precision medicine is also called personalized medicine or individualized medicine is an approach that protects health and treat diseases taking into account an individual variability in genes, environment and lifestyle for every individual.

The global artificial intelligence (AI) in precision medicine market is expected to grow from $1.41 billion in 2022 to $1.82 billion in 2023 at a compound annual growth rate (CAGR) of 29.3%.

Read here the latest updates on the Cell Surface Markers Market published by CMI team.

Non-Oncology Precision Medicine market is segmented by Ecosystem, and by Application. Players, stakeholders, and other participants in the global Non-Oncology Precision Medicine market will be able to gain the upper hand as they use the report as a powerful resource.

Get more details @ http://bit.ly/2l3rNQ4 Key industry players contributing to global precision medicine market share include Pfizer, Roche, Covance, Novartis, Qiagen, Biocrates Life Sciences, Teva Pharmaceutical, Nanostring Technologies, Laboratory Corporation of America Holdings, Tepnel Pharma Services, Intomics, Ferrer InCode, Silicon Biosystems, Eagle Genomics, Medtronic, and Quest Diagnostics

Precision Medicine Market size was over USD 39 billion in 2015, and is anticipated to grow at 10.5% CAGR from 2016 to 2023. Get more details @ https://goo.gl/y9VxzK

The global companion diagnostics market is anticipated to grow at a CAGR of 13.29%, and is estimated to reach $15441.90 million by 2030. Get Free Sample Report.

Get more details @ http://bit.ly/2ekRPfD Some of the major players of global precision medicine market are Intomics, F. Hoffmann-La Roche, NanoString Technologies, Laboratory Corporation of America Holdings, Biocrates Life Sciences, Teva Pharmaceutical, Tepnel Pharma Services, Novartis, Silicon Biosystems, Quest Diagnostics and Ferrer InCode.

Get more details @ http://bit.ly/2ekRPfD Some of the major players of global precision medicine market are Intomics, F. Hoffmann-La Roche, NanoString Technologies, Laboratory Corporation of America Holdings, Biocrates Life Sciences, Teva Pharmaceutical, Tepnel Pharma Services, Novartis, Silicon Biosystems, Quest Diagnostics and Ferrer InCode.

Get more details @ http://bit.ly/2ekRPfD Key industry players contributing to global precision medicine market share include Pfizer, Roche, Covance, Novartis, Qiagen, Biocrates Life Sciences, Teva Pharmaceutical, Nanostring Technologies, Laboratory Corporation of America Holdings, Tepnel Pharma Services, Intomics, Ferrer InCode, Silicon Biosystems, Eagle Genomics, Medtronic, and Quest Diagnostics.

The report assures that the market will grow manifold and it will register a 14.7% CAGR between 2016 and 2024.

The latest report by Precision Business Insights, titled “Personalized Medicine Market” covers complete information on market size, share, growth, trends, segment analysis, key players, drivers, and restraints.

The global saffron market size reached US$ 518.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,017.8 Million by 2032, exhibiting a growth rate (CAGR) of 7.76% during 2024-2032.

The 7 major pneumonia markets are expected to exhibit a CAGR of 5.32% during 2024-2034.

The global dermatology diagnostic devices market size reached US$ 16.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 34.4 Billion by 2032, exhibiting a growth rate (CAGR) of 8.6% during 2024-2032.

Precision Oncology Market

According to the latest research report by IMARC Group, The United States digital PCR market size reached US$ 1.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.0 Billion by 2032, exhibiting a growth rate (CAGR) of 22.20% during 2024-2032. More Info:- https://www.imarcgroup.com/united-states-digital-pcr-market

Digital Biomarkers Market report by Precision Business Insights provides in-depth research analysis of market size, share and growth

The Vietnam Pharmaceutical Market stands as a vital component of the global healthcare framework, experiencing substantial growth fueled by ongoing innovation and a rising demand for cutting-edge therapeutic solutions. The pharmaceutical market size is projected to swell from a valuation of USD 570.01 billion in 2024 to an impressive USD 1022.61 billion by 2029. This surge represents a robust compound annual growth rate (CAGR) of 12.14% during the forecast period (2024-2029).

The Vietnam Pharmaceutical Market stands as a vital component of the global healthcare framework, experiencing substantial growth fueled by ongoing innovation and a rising demand for cutting-edge therapeutic solutions. The pharmaceutical market size is projected to swell from a valuation of USD 570.01 billion in 2024 to an impressive USD 1022.61 billion by 2029. This surge represents a robust compound annual growth rate (CAGR) of 12.14% during the forecast period (2024-2029).

The Vietnam Pharmaceutical Market stands as a vital component of the global healthcare framework, experiencing substantial growth fueled by ongoing innovation and a rising demand for cutting-edge therapeutic solutions. The pharmaceutical market size is projected to swell from a valuation of USD 570.01 billion in 2024 to an impressive USD 1022.61 billion by 2029. This surge represents a robust compound annual growth rate (CAGR) of 12.14% during the forecast period (2024-2029).

Global liquid biopsy for cancer diagnostics market size is expected to reach $16.42 Bn by 2028 at a rate of 15.7%, segmented as by type, product, services

Global cybersecurity market size is expected to reach $393.72 Bn by 2028 at a rate of 12.2%, segmented as by solution, infrastructure protection, network security, endpoint security, data security, application security, cloud security

The India Diagnostic Lab Market Size is estimated at USD 84.18 billion in 2024. Projections indicate further expansion, with expectations to reach USD 109.92 billion by 2029, representing a robust compound annual growth rate (CAGR) of 5.48% during the forecast period (2024-2029).

The report Personalized Medicine Market analyzes the Market status, Market share, growth rate, future trends, Market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

The healthcare market in Indonesia was majorly impacted by the implementation of JKN (Indonesian National Health Insurance) as the demand for affordable/primary healthcare services, laboratory services, and generic medicines increased.

The Biosimulation Market Report provides a comprehensive analysis of the global Biosimulation market, highlighting key trends, drivers, challenges, and opportunities shaping the industry.

Global medical foods for inborn errors of metabolism market size is expected to reach $4.83 Bn by 2028 at a rate of 11.9%, segmented as by product, amino acid, glytactin with gmp amino acid-modified infant formula with iron

The global consumption of spices market is valued at US$ 164.1 billion in 2024, with projections indicating a steady rise at a Compound Annual Growth Rate (CAGR) of 5.1%, reaching US$ 244.8 billion by 2032. Persistence Market Research forecasts reveal that Europe and North America are witnessing the most rapid expansion in the spices market. Together, these regions command a market volume share of over 30% as of 2023.

The expanding healthcare industry and the elevating focus on patient safety are among the primary factors driving the whole imaging market. In addition to this, the rising prevalence of cancer, owing to the changing lifestyles, escalating smoking habits of consumers, genetic mutation, etc Get a PDF Sample for more detailed market insights: Visit the following link: https://www.imarcgroup.com/whole--imaging-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099

Global Market Insights add New Global Artificial Intelligence in Healthcare Market report provides in-depth information about market overview, top vendors, Key market highlights, product types, market drivers, challenges, trends, industry landscape, size and forecast, five forces analysis, Key leading countries/Region.

The global brachytherapy market is projected to be worth USD 548.8 Million by 2027, according to a current analysis by Emergen Research. The brachytherapy market is experiencing an increased demand attributed to its growing application in the treatment of cancer.

According to the latest research report by IMARC Group, The global particle size analysis market size reached US$ 378.5 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 510.1 Million by 2028, exhibiting a growth rate (CAGR) of 4.7% during 2023-2028. More Info:- https://www.imarcgroup.com/particle-size-analysis-market

Cancer Stem Cells Therapy Market report gives attention to market segmentation, market size, and forecast of 2023-2032 to help stakeholders in making a good decision for the future investments. Urinary Catheters industry report segmented into types, application, and regions with providing production, revenue, import/export.

According to the latest research report by IMARC Group, The global particle size analysis market size reached US$ 397.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 595.8 Million by 2032, exhibiting a growth rate (CAGR) of 4.5% during 2024-2032. More Info:- https://www.imarcgroup.com/particle-size-analysis-market

The global Research Antibodies Market size was USD 1.41 Billion in 2021 and is expected to register a revenue CAGR of 4.9% during the forecast period, according to latest analysis by Emergen Research. An increase in research and development (R&D) activities related to the fields of neurobiology, oncology and stem cell research, the increasing incidence of cancer and infectious diseases, and the growing demand from the biopharmaceutical industry for these antibiotics are the main drivers of the market. increase the revenue. Research antibodies are antibodies that can bind to specific molecules, which are used as basic detection tools needed in scientific research and are also important tools for studying protein function in cell.

The Veterinary Medicine Market Report provides an exhaustive analysis of the growth drivers, current trends, restraining forces, and opportunities present in the market.

The drone logistics and transportation market is projected to grow from USD 534 million in 2022 to USD 17,881 million by 2030, at a CAGR of 55.1% from 2022 to 2030.

The global industrial agitators market size is estimated to be worth USD 2.6 billion in 2023 and is projected to reach USD 3.2 billion by 2028, at a CAGR of 4.0% during the forecast period. Increasing demand for homogeneous mixing, growing need for energy efficient mixing equipment or industrial mixer in pharmaceutical, chemical and food & beverage industries, and growing adoption of customized industrial agitators are some of the major factors driving the industrial agitators market growth.

The global nucleic acid labeling market size was USD 2.16 billion in 2022 and is expected to reach USD 4.32 billion in 2032, and register a revenue CAGR of 8% during the forecast period. Rising demand for personalized medicine, Genomics research, and improvements in Molecular Diagnostics are major factors driving the market revenue growth. To visualize and analyze Gene Expression, protein interactions, and other biological processes, nucleic acids must be labeled with fluorescent, radioactive, or other tags. This is known as nucleic acid labeling.

The Artificial Intelligence In Healthcare Market Report provides a comprehensive analysis of the global Artificial Intelligence In Healthcare market, highlighting key trends, drivers, challenges, and opportunities shaping the industry.

According to the latest research report by IMARC Group, The global genotyping market reached a value of US$ 14.77 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 36.75 Billion by 2027, exhibiting a CAGR of 15.60% during 2022-2027. More Info:- https://www.imarcgroup.com/genotyping-market

The research firm Contrive Datum Insights has just recently added to its database a report with the heading global Alternative Medicines and Therapies Market .Both primary and secondary research methodologies have been utilised in order to conduct an analysis of the worldwide Alternative Medicines and Therapies Market . In order to provide a comprehensive comprehension of the topic at hand, it has been summed up using appropriate and accurate market insights. According to Contrive Datum Insights, this worldwide comprehensive report is broken up into several categories in order to present the data in a way that is understandable, succinct, and presented in a professional manner.Natural treatments that are different from traditional medications or drugs are referred to as alternative medicine and therapies. A variety of natural and non-mineral, non-vitamin, and alternative medicine therapies are available.

Digital healthcare is the convergence of digital technologies withhealth,?healthcare, living, and society to enhance the efficiency ofhealthcare delivery and make medicines more personalized and precise. In 2018, the global Digital Healthcare market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.